Abstract
Background
Objective
Data Source
Study Eligibility Criteria, Participants, and Interventions
Study Appraisal and Synthesis Methods
Results
Conclusions
Keywords
Guide to Clinical Preventive Services, 2010–2011. AHRQ Publication No. 10–05145. Rockville, MD: Agency for Healthcare Research and Quality; September 2010. Available at: http://www.ahrq.gov/clinic/pocketgd.htm. Accessed October 26, 2011.
Maternal and Child Health Bureau. Achieving and measuring success: A national agenda for children with special health care needs. Available at: http://www.mchb.hrsa.gov/programs/specialneeds/achievingsuccess.html. Accessed March 1, 2011.
Methods
W.K. Kellogg Foundation. Logic Model Development Guide. January, 2004. Available at: http://www.wkkf.org/knowledge-center/publications-and-resources.aspx. Accessed April 21, 2010.
Screening/Specific Disorders | Setting | Interventions/Outcomes |
---|---|---|
Mass screening Population surveillance Preventive health services Child development Developmental disabilities Language disorders Child behavior disorders Cerebral palsy Autistic disorder Mental retardation Vision disorders Hearing loss Lead poisoning Anemia Iron deficiency Hypertension Obesity Depression Tuberculosis Sexually transmitted infections | Primary health care Community health centers Managed care programs Group practice | Physician’s practice patterns Child health services Medical records systems, computerized Decision support systems, clinical Information systems Education, medical Education, medical, continuing Insurance, health, reimbursement Total quality management Quality assurance, health care Referral and consultation Primary prevention Health care disparities Health care costs Quality of health care Outcome assessment Process assessment |

Screening Tests
Interventions
Outcomes
Database Search
Selection of Articles
Specific Categories of Excluded Studies
Results

Author, Year, Design | Condition(s) Being Screened and Screening Test(s) | Preintervention or Control Group Screening (% of Patients Screened, Unless Otherwise Specified) | Postintervention or Experimental Group Screening (% of Patients Screened, Unless Otherwise Specified) | Significance Testing (P Value Unless Otherwise Specified) | Nature of the Intervention, Setting/Population, and Other Comments About the Study |
---|---|---|---|---|---|
Randomized controlled trials | |||||
1. Margolis et al (2004) RCT 20 | Lead poisoning, anemia, and tuberculosis: | Intervention: Process improvement methods (aka “knowledge translation”) to improve office systems around preventive care services.
Setting/population: 44 practices in North Carolina were randomized to intervention vs usual care; n = ∼660 each for postintervention control and experimental groups; children aged 24–30 months. Other comments: Data were collected pre- and post-intervention for both control and experimental group practices. Tuberculosis screening was PPD, Mantoux test, or risk assessment | |||
Serum lead level: | |||||
Intervention | 23% | 68% | <0.05 | ||
Control | 18% | 30% | |||
Hematocrit: | |||||
Intervention | 65% | 79% | <0.05 | ||
Control | 64% | 71% | |||
Tuberculosis screening: | |||||
Intervention | 34% | 54% | <0.05 | ||
Control | 30% | 32% | |||
2. Minkovitz et al (2003) RCT 35 | Developmental problems: | Intervention: Healthy Steps (HS) program Co-located developmental specialists to enhance well-child visits; also conducted home visits, provided telephone information line for parents about development, written materials, parent groups, linkages to community resources Setting/population: 15 practices randomized in 14 states; experimental n = 2021 patients, control n = 1716 patients; post-intervention data were collected for children aged 30−33 months. Other comments: Parents reported any developmental screening questions (not specifically whether a formal tool was used) | |||
Parent-reported developmental assessment | 41%–43% | 82%–84% | <0.001 | ||
3. Scholes et al (2006) RCT 27 | Chlamydia infection: | Intervention: Practice and patient-level interventions
Setting/population: 23 practices in Washington state; experimental n = 3511 patients, control n = 3649 patients; females aged 14–20 years. | |||
Urine Chlamydia screening | Practice-level intervention: 37.5% | 39.6% | 0.31 | ||
EMR reminder: 40.8% | 42.6% | 0.27 | |||
4. Shafer MA et al (2002) RCT 23 | Chlamydia infection: | Intervention: Quality improvement initiative within managed care network
Setting/population: 10 pediatric practices in California; experimental n = 1017 patients, control n = 1194 patients; sexually active adolescent females. | |||
Urine Chlamydia screening | 21% | 65% | <0.001 | ||
5. Tebb et al (2009) RCT 29 | Chlamydia infection: | Intervention: Quality improvement initiative within managed care network
Setting/population: 10 pediatric practices in California; n was not reported; sexually active adolescent females Other comments: Data were collected pre- and post-intervention for both control and experimental group practices. | |||
Urine Chlamydia screening | |||||
Intervention | 26% | 42% | <0.001 | ||
Control | 32% | 30% | |||
Pre-post intervention design | |||||
6. Adams et al (2003) Pre-post 37 | Developmental problems, anemia, lead poisoning, hearing and vision problems: | Relative risk (95% confidence interval): | Intervention: EMR template with prompts to improve preventive care services
Setting/population: One practice in Massachusetts with >28,000 visits/year; preintervention n = 235 patients; post-intervention n = 986 patients; children aged 0–5 years Other comments: Preintervention group had paper charts with well-child visit templates; sample for specific tests varied because some tests are recommended only for a subset based on age. | ||
Language development | 65.1% | 70.0% | 1.07 (0.97−1.09) | ||
Behavior/social development | 26.4% | 65.7% | 1.16 (1.04−1.28) | ||
Motor development | 63.8% | 73.9% | 2.49 (2.00−3.10) | ||
Hematocrit | 82.5% | 85.3% | 1.03 (0.91−1.17) | ||
Serum lead level | 66.7% | 79.1% | 1.19 (0.99−1.43) | ||
Vision | 42.9% | 50.0% | 1.17 (0.80−1.70) | ||
Hearing | 33.3% | 48.3% | 1.45 (0.92−2.28) | ||
7. Applegate et al (2003) Pre-post 33 | Behavior, developmental and emotional problems: | Intervention: Provider education and support tools to implement Pediatric Symptom Checklist (PSC); intervention was 2 stages
Setting/population: One academic pediatric practice; pre-intervention n = 16 patients; post-intervention n = 38 patients; children aged 6–16 years. Other comments: No significance testing reported | |||
Discussion about behavior, developmental or emotional problems (no. items discussed per visit) | 1.6 items | 10.4 items per visit after Stage 1; 9.9 items per visit after Stage 2 | |||
Intervention for behavior and emotional problems (# of interventions per visit) | 0 interventions | 0.125 interventions per visit after Stage 1; 1.9 interventions per visit after Stage 2 | |||
8. Block et al (1996) Pre-post 40 | Follow up of elevated lead levels: | Intervention: Nurse-led protocol to follow up elevated lead levels
Setting/population: One academic family medicine practice in Pennsylvania; preintervention n = 22 patients with abnormal lead levels, postintervention n = 99 patients with abnormal lead levels Other comments: No significance testing reported | |||
Follow up plan in chart | 32% | 100% | |||
Follow up serum lead level done | 9% | 65% | |||
Parent education about reducing exposure, if persistently high levels | Not measured | 28% | |||
9. Bordley et al (2001) Pre-post 22 | Anemia, lead poisoning, tuberculosis: | Intervention: Quality improvement intervention to improve preventive care:
Setting/population: 8 practices in North Carolina, pre-intervention n = 339 patients; post-intervention n = 300; children aged 24−30 months Other comments: Lead and tuberculosis screening was risk assessment and laboratory/skin testing, if indicated | |||
Hematocrit | 45% | 67% | 0.001 | ||
Lead screening | 12% | 48% | 0.001 | ||
Tuberculosis screening | 50% | 52% | NS | ||
10. Dunlop et al (2007) Pre-post 32 | Obesity: | Intervention: Provider training and support tools for obesity. 2-stage intervention:
Population/setting: 6 academic family medicine and pediatric practices in Georgia; pre-intervention n = 466; Stage 1 n = 538, Stage 2 n = 344; children aged 2−17 years | |||
BMI percentile documented in chart | 12% | 15% after Stage 1 | NS | ||
28% after Stage 2 | <0.05 | ||||
Nutrition and activity history | 50% | 56% after Stage 1 | NS | ||
81% after Stage 2 | <0.05 | ||||
Nutrition and activity counseling | 33% | 35% after Stage 1 | NS | ||
47% after Stage 2 | <0.05 | ||||
11. Lannon et al (2008) Pre-post 21 | Developmental problems | Intervention: Bright Futures Training Intervention Project: learning collaborative/quality improvement initiative to improve preventive care services
Population/setting: 15 practices in 9 states; experimental n = 305 patients, control n = 171 patients; children aged 0−5 years Other comments: No participating practices used formal developmental screening tools preintervention. | |||
PEDS or ASQ | 30% (received any developmental screening) | 45% (using structured tool, eg, ASQ) | NS | ||
12. Polacsek et al (2009) Pre-post 25 | Obesity: | Intervention: Learning collaborative
Population/setting: 12 practices in Maine; n = 600 patients with visits during both pre and post intervention periods; children aged 5–18 years. | |||
BMI documented in chart | 38% | 94% | <0.001 | ||
Screening with pre-visit, self-administered tool to assess patient’s behavior around nutrition and physical activity | Not measured | 82% | <0.001 | ||
13. Shaw et al (2006) Pre-post 19 | Lead poisoning, anemia, tuberculosis, hypertension: | Interventions: State-wide learning collaborative with 4 1-day learning sessions
Population/setting: 31 practices in Vermont; pre- and post-intervention n = each approx 930 patients; children aged 2–4 years Other comments: Tuberculosis and lead screening were risk assessment and laboratory/skin testing, if indicated. | |||
Lead screening | 72% | 85% | 0.001 | ||
Hematocrit | 70% | 74% | NS | ||
Vision screening | 62% | 75% | 0.013 | ||
Tuberculosis screening | 18% | 39% | 0.001 | ||
Blood pressure | 85% | 82% | NS | ||
14. Young et al (2006) Pre-post 18 | Anemia, vision problems, hypertension, obesity: | Intervention: Learning collaborative
| |||
Hematocrit | 49% | 57% | 0.36 | ||
Vision screening | 46% | 75% | 0.007 | ||
BP screening | 59% | 74% | 0.010 | ||
BMI recorded | 32% | 45% | 0.078 | ||
Postintervention with and without a control group | |||||
15. Gioia (2001) Post intervention without control group 38 | Lead poisoning: | Intervention: EMR with point-of-care reminders displayed on screen Population/setting: Single practice in New York; n = 208 patients; children born in 1998 | |||
Serum lead level | Not measured | 81% | |||
16. Hartmann et al (2006) Postintervention without control group 34 | Vision disorders: monocular visual acuity and stereopsis | Intervention: Vision screening with specific tools for assessing monocular visual acuity and stereopsis.
Population/setting: 28 practices in Ohio and Tennessee; n = 627 patients; children aged 3–4 years. | |||
3 year olds | Not measured | 70%–85% | |||
4 year olds | Not measured | 93%–94% | |||
17. Hull et al. (2008) Postintervention with concurrent control group 39 | Lead poisoning, anemia, hearing, vision: | Intervention: Nurse-led protocol
| |||
“Laboratory testing” (serum lead level and hematocrit) | 74% | 100% | <0.001 | ||
Hearing | 12% | 100% | <0.001 | ||
Vision | 23% | 100% | <0.001 | ||
18. Niederman et al (2007) Postintervention with concurrent control group 36 | Anemia and lead poisoning: | Intervention: Healthy Steps (HS) program implemented in a resident continuity clinic. Population/setting: One academic practice in Illinois; experimental n = 71, control n = 192 patients; children aged at least 18 months Other comments: Control group was patients in the practice but not enrolled in HS | |||
Hematocrit | 77% | 73% | NS | ||
Serum lead level | 64% | 67% | NS | ||
19. Ozer et al. (2005) Postintervention with concurrent control group 31 | Adolescent health risk behaviors: | Intervention: Provider training, patient questionnaire, and prompts to facilitate communication about adolescent risk behaviors 2-stage intervention:
Population/setting: 4 practices in California (2 practices received the intervention); experimental n = 1717, control n = 911 patients; adolescents aged 14–17 years Other comments: Control practices’ screening did not differ over study period | |||
Adolescent health screening questionnaire | Not measured | 80% | NA | ||
Provider asked about alcohol use during visit | 67% | 82% after Stage 1 | <0.01 | ||
83% after Stage 2 | <0.001 | ||||
Provider counseled on alcohol use during visit | 59% | 77% after Stage 1 | <0.01 | ||
81% after Stage 2 | <0.001 | ||||
20. Schonwald et al (2009) Post-intervention without cuncurrent control group 30 | Behavior and development problems: | Intervention: Implementation of developmental screening using PEDS
Population/setting: 1 practice in Massachusetts; pre-intervention n = 338 patients, post-intervention n = 278 patients; children aged 20−40 months Other comments: Use of structured developmental assessments was not routine preintervention; authors reported an increase in developmental concerns identified post-intervention (21% vs 26%, P = 0.05); proportion of children referred for developmental concerns did not change postintervention (10% vs 11%). | |||
PEDS | Not measured | 61% | |||
Time series | |||||
21. Earls et al (2006) Time series 28 | Developmental problems: | Intervention: Quality improvement initiative to improve child development services:
Other comments: No significance testing reported | |||
ASQ | 24% | 62% at year 2; 76% at year 5 | |||
22. King et al (2010) Time series 24 | Development problems: | Intervention: Provider and staff education, physician champion identification
Population/setting: 17 practices from 15 states; pre- and post-intervention n ≈1020 children total; children aged 8−36 months Other comments: Postintervention screening varied among practices (33%–100%); no significance testing reported | |||
PEDS or ASQ | Not measured | 67% at 1 month; 85% at 9 months | |||
23. Pomietto et al (2009) Time series 26 | Obesity: | Intervention: Learning collaborative, combined with community and policy-level interventions.
Population/setting: 8 practices in Washington state. Chart audits of 20 pediatric patients per month per practice were tracked for 9 months. Age range of patients was not reported. Other comments: No significance testing reported | |||
BMI and weight classification documented in chart | Not measured | 49% at 1 month; 94% at 9 months |
Types of Interventions
Interventions to Increase Follow-Up of Abnormal Screening Results
Discussion
Conclusion
Acknowledgments
Appendix
Search
References
- Prevention: a new focus for the country but old stuff for pediatricians.Acad Pediatr. 2010; 10: 367-368
- Recommendations for Preventive Pediatric Health Care.Pediatrics. 2007; 120: 1376
Guide to Clinical Preventive Services, 2010–2011. AHRQ Publication No. 10–05145. Rockville, MD: Agency for Healthcare Research and Quality; September 2010. Available at: http://www.ahrq.gov/clinic/pocketgd.htm. Accessed October 26, 2011.
- Bridging the quality chasm for children: need for valid, comprehensive measurement tools.Arch Pediatr Adolesc Med. 2007; 161: 909-910
- Implementation of and barriers to routine HIV screening for adolescents.Pediatrics. 2009; 124: 1076-1084
- Barriers to enhancing practice-based developmental services.J Dev Behav Pediatr. 2006; 27 (discussion S34–37, S50–32): S30-S33
- Perceived barriers to and facilitators of the implementation of priority clinical preventive services guidelines.Am J Manag Care. 2007; 13: 150-155
- Improving colorectal cancer screening in primary care practice: innovative strategies and future directions.J Gen Intern Med. 2007; 22: 1195-1205
- Interventions to improve the delivery of preventive services in primary care.Am J Public Health. 1999; 89: 737-746
- Child health services research. Challenges and opportunities.JAMA. 1997; 277: 1787-1793
Maternal and Child Health Bureau. Achieving and measuring success: A national agenda for children with special health care needs. Available at: http://www.mchb.hrsa.gov/programs/specialneeds/achievingsuccess.html. Accessed March 1, 2011.
- Evidence for family-centered care for children with special health care needs: a systematic review.Acad Pediatr. 2011; 1: 136-143
- Health care transition for youth with special health care needs.Journal of Adolescent Health. March 23 2012; ([Epub ahead of print.])
- A review of the evidence for the medical home for children with special health care needs.Pediatrics. 2008; 122: e922-e937
- The future of health insurance for children with special health care needs.Pediatrics. 2009; 123: e940-e947
W.K. Kellogg Foundation. Logic Model Development Guide. January, 2004. Available at: http://www.wkkf.org/knowledge-center/publications-and-resources.aspx. Accessed April 21, 2010.
- Crossing the Quality Chasm: A New Health System for the 21st Century.National Academies Press, Washington, DC2001
- Evaluation of a learning collaborative to improve the delivery of preventive services by pediatric practices.Pediatrics. 2006; 117: 1469-1476
- Statewide quality improvement outreach improves preventive services for young children.Pediatrics. 2006; 118: e1039-e1047
- Practice based education to improve delivery systems for prevention in primary care: randomised trial.BMJ. 2004; 328: 388
- The Bright Futures Training Intervention Project: implementing systems to support preventive and developmental services in practice.Pediatrics. 2008; 122: e163-e171
- Improving preventive service delivery through office systems.Pediatrics. 2001; 108: E41
- Effect of a clinical practice improvement intervention on Chlamydial screening among adolescent girls.JAMA. 2002; 288: 2846-2852
King TM, Tandon SD, Macias MM, et al. Implementing developmental screening and referrals: lessons learned from a national project. Pediatrics. Feb;125:350–360.
- Impact of a primary care intervention on physician practice and patient and family behavior: keep ME Healthy—the Maine Youth Overweight Collaborative.Pediatrics. 2009; 123: S258-S266
- Small steps to health: building sustainable partnerships in pediatric obesity care.Pediatrics. 2009; 123: S308-S316
- A randomized trial of strategies to increase chlamydia screening in young women.Prev Med. Oct 2006; 43: 343-350
- Setting the stage for success: implementation of developmental and behavioral screening and surveillance in primary care practice—the North Carolina Assuring Better Child Health and Development (ABCD) Project.Pediatrics. 2006; 118: e183-e188
- Screening for asymptomatic Chlamydia infections among sexually active adolescent girls during pediatric urgent care.Arch Pediatr Adolesc Med. 2009; 163: 559-564
- Routine developmental screening implemented in urban primary care settings: more evidence of feasibility and effectiveness.Pediatrics. 2009; 123: 660-668
- Increasing the screening and counseling of adolescents for risky health behaviors: a primary care intervention.Pediatrics. 2005; 115: 960-968
- Improving providers’ assessment and management of childhood overweight: results of an intervention.Ambul Pediatr. 2007; 7: 453-457
- Clinical case study: pediatric residents’ discussions of and interventions for children’s behavioral and emotional problems.J Pediatr Psychol. 2003; 28: 315-321
- Project Universal Preschool Vision Screening: a demonstration project.Pediatrics. 2006; 117: e226-e237
- A practice-based intervention to enhance quality of care in the first 3 years of life: the Healthy Steps for Young Children Program.JAMA. 2003; 290: 3081-3091
- Healthy Steps for Young Children program in pediatric residency training: impact on primary care outcomes.Pediatrics. 2007; 120: e596-e603
- Use of an electronic medical record improves the quality of urban pediatric primary care.Pediatrics. 2003; 111: 626-632
- Quality improvement in pediatric well care with an electronic record.Proc AMIA Symp. 2001; : 209-213
- EPSDT preventive services in a low-income pediatric population: impact of a nursing protocol.Clin Pediatr (Phila). 2008; 47: 137-142
- Difficulties in evaluating abnormal lead screening results in children.J Am Board Family Pract. 1996; 9: 405-410
Holden DJ, Jonas DE, Porterfield DS, et al. Systematic review: enhancing the use and quality of colorectal cancer screening. Ann Intern Med. 18;152:668–676.
- Strategies to improve immunization rates and well-child care in a disadvantaged population: a cluster randomized controlled trial.Arch Pediatr Adolesc Med. 2004; 158: 162-169
- Influenza immunization in a managed care organization.J Gen Intern Med. 1998; 13: 469-475
- Different paths to high-quality care: three archetypes of top-performing practice sites.Ann Fam Med. 2007; 5: 233-241
- Interventions to increase recommendation and delivery of screening for breast, cervical, and colorectal cancers by healthcare providers systematic reviews of provider assessment and feedback and provider incentives.Am J Prev Med. 2008; 35: S67-S74
- A pediatric-focused review of the performance incentive literature.Curr Op Pediatr. 2007; 19: 719-725
- Client-directed interventions to increase community demand for breast, cervical, and colorectal cancer screening a systematic review.Am J Prev Med. 2008; 35: S34-S55